Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANAPTYSBIO, INCANAB · Entity 4640 | CHIEF LEGAL OFFICER | February 11, 2026 | February 13, 2026 |
| OTONOMY, INC.OTIC · Entity 116495 | GC & Chief Compliance Officer | February 01, 2018 | February 05, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANAPTYSBIO, INC
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,835 |
Ending reported balance
After 2026-02-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-11 · Exercise / conversion · Acquired 10,000 · Balance 22,835 Row 2 · 2026-02-11 · Sale · Disposed 10,000 · Balance 12,835 F1: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.70 · Expires 2031-02-09 | Direct | 35,000 |
Reported balance
After 2026-02-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-11 · Exercise / conversion · Disposed 10,000 · Balance 35,000 F2: The stock option is fully vested. F3: In addition to the options to purchase a total of 35,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 436,010 shares of common stock, which options vest according to their terms. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025.
F2: The stock option is fully vested.
F3: In addition to the options to purchase a total of 35,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 436,010 shares of common stock, which options vest according to their terms.
OTONOMY, INC.
Report date February 01, 2018 · Filed February 05, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.80 · Expires 2028-01-31 | Direct | 110,000 |
Reported balance
After 2018-02-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-02-01 · Grant · Acquired 110,000 · Balance 110,000 F1: One-fourth (1/4) of the shares subject to the option vest on February 1, 2019 and one forty-eighth (1/48) of the shares vest monthly thereafter. F2: In addition to the options acquired as set forth in Table II, the Reporting Person currently holds options to purchase up to an aggregate of 146,665 shares of common stock, which options vest according to their terms. |
Filing footnotes · ownership attribution and instrument terms
F1: One-fourth (1/4) of the shares subject to the option vest on February 1, 2019 and one forty-eighth (1/48) of the shares vest monthly thereafter.
F2: In addition to the options acquired as set forth in Table II, the Reporting Person currently holds options to purchase up to an aggregate of 146,665 shares of common stock, which options vest according to their terms.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2015 Filed Jun 27, 2017 17:09 UTC | OTONOMY, INC. OTIC · Entity 116495 | GrantCommon Stock | 648 | $20.37 | $13,199.76 |
DisclosureSEC source: 0001209191-17-041981 · doc4.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · GC & Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 648 F1 · balance_after: Acquired pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.